Suppr超能文献

原发性阴道恶性肿瘤的特征与生存情况:基于德国全国癌症登记数据的分析

Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data.

作者信息

Forner Dirk Michael

机构信息

Department of Gynaecology, Gynaecologic Oncology and Obstetrics, Evangelisches Krankenhaus Köln Kalk, Buchforststrasse 2, 51103, Köln, Germany.

出版信息

J Cancer Res Clin Oncol. 2023 Mar;149(3):1115-1122. doi: 10.1007/s00432-022-03982-7. Epub 2022 Mar 21.

Abstract

BACKGROUND

Vaginal neoplasms are rare. To study the survival of patients depending on tumour characteristics and age, the data from the national cancer registries in Germany were analysed.

METHODS

In a retrospective analysis, data from 2006 to 2015 on disease stage, survival, and factors that might affect prognosis were analysed.

RESULTS

Altogether, out of 4004 datasets, 2194 were deemed adequate to be included in the analysis. Overall survival at 5 years (5YSR) and relative survival (5RSR) were 48.6% (95%CI 45.4-52.1%) and 58.7% (95%CI 55.3-61.2%) for carcinomas, but significantly worse at 20.2% (95%CI 8.3-32.0%) and 24.2% (95%CI 16.4-32.0%) for melanomas and 38.3% (95%CI 23.3-53.5%) and 44.4% (95%CI 31.5-56.8%) for sarcomas. 5YSR and 5RSR correlated significantly with FIGO stages (5YSR: 66.9-10.1%; 5RSR: 81.7-11.9%, p = 0.04). Furthermore, survival depended on the absence of LN metastases (5RSR: 59.1% vs. 38.0%, p < 0.001), and the tumour grading had an influence (5RSR: 83.7-52.1%). We also noted that prognosis was worse for older patients ≥75 years (5RSR:51.2%) than for patients <55 years (62.2%) and 55-74 years of age (61.6%).

CONCLUSION

Unless LN metastases, local advanced tumours and G3 grading are associated with a worse prognosis. Relative survival of older patients decreases, perhaps indicating that treatment compromises have been made.

摘要

背景

阴道肿瘤较为罕见。为了根据肿瘤特征和年龄研究患者的生存率,对德国国家癌症登记处的数据进行了分析。

方法

在一项回顾性分析中,分析了2006年至2015年有关疾病分期、生存率及可能影响预后因素的数据。

结果

在4004个数据集中,共有2194个被认为适合纳入分析。癌的5年总生存率(5YSR)和相对生存率(5RSR)分别为48.6%(95%CI 45.4 - 52.1%)和58.7%(95%CI 55.3 - 61.2%),但黑色素瘤的5YSR和5RSR显著更差,分别为20.2%(95%CI 8.3 - 32.0%)和24.2%(95%CI 16.4 - 32.0%),肉瘤的5YSR和5RSR分别为38.3%(95%CI 23.3 - 53.5%)和44.4%(95%CI 31.5 - 56.8%)。5YSR和5RSR与国际妇产科联盟(FIGO)分期显著相关(5YSR:66.9 - 10.1%;5RSR:81.7 - 11.9%,p = 0.04)。此外,生存率取决于有无淋巴结转移(5RSR:59.1%对38.0%,p < 0.001),且肿瘤分级有影响(5RSR:83.7 - 52.1%)。我们还注意到,≥75岁的老年患者预后比<55岁(62.2%)和55 - 74岁(61.6%)的患者更差(5RSR:51.2%)。

结论

除非有淋巴结转移、局部晚期肿瘤和G3分级与预后较差相关。老年患者的相对生存率降低,这可能表明在治疗上做出了妥协。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验